Status:

COMPLETED

Neulasta in Type 1 Diabetes

Lead Sponsor:

University of Florida

Collaborating Sponsors:

Juvenile Diabetes Research Foundation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

12-45 years

Phase:

PHASE1

Brief Summary

The primary purpose of this study is to find out if giving a 12 week course of Neulasta (Pegylated granulocyte colony stimulating factor (GCSF)) to people with type 1 diabetes (T1D) is safe. The secon...

Detailed Description

As a participant in this study the following will happen: Blood test, Mixed meal Tolerance Test (MMT) to find out how much C-peptide is being produced, Human Leukocyte Antigen (HLA) test, Hemoglobin ...

Eligibility Criteria

Inclusion

  • Must be \> 12 years old and have a confirmed diagnosis of "recent onset T1D" as defined by:
  • T1D for \< 6 months,
  • Stimulated C-peptide ≥ 0.2 pmol/ml
  • Presence of at least one diabetes-related autoantibody (e.g., GAD, IA-2, IAA, ICA)
  • Normal screening values for CBC
  • Willing to comply with intensive diabetes management
  • No history of allergy to GCSF
  • Females having reproductive potential must be willing to avoid pregnancy and have a negative pregnancy test

Exclusion

  • Known hypersensitivity to E.Coli-derived proteins, pegfilgrastim, Filgrastim, or any other component of the product
  • Chronic use of steroids or other immunosuppressive agents
  • Active infection
  • Inability to maintain intensive diabetes management
  • Pregnancy
  • History of malignancy
  • Currently participating in another type 1 diabetes treatment study.
  • Use of non-insulin pharmaceuticals that affect glycemic control

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2014

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00662519

Start Date

April 1 2008

End Date

March 1 2014

Last Update

April 9 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida

Gainesville, Florida, United States, 32610